Cronos Q4 2022 Revenue Declines 11% YoY, What About Net Loss?

Zinger Key Points
  • Consolidated net revenue increased 23% in full year 2022 compared to full year 2021.
  • Ended 2022 with $878 million in cash and short-term investments.

Cronos Group Inc. CRON CRON net revenue in 2022 was $91.9 million, a 23% increase compared to $74.4 million in 2021.

Q4 2022 Financial Highlights

  • Net revenue of $22.9 million, an 11% decrease compared to $25.8 million in Q4 2021.

  • Gross loss was $234,000, compared to a gross profit of $1.9 million in Q4 2021.

  • Adjusted EBITDA was a loss of $21.2 million in Q4 2022 improved by $6.1 million from Q4 2021.

  • Net loss was $78.9 million, a 41% decrease compared to a loss of $133.9 million in Q4 2021.

  • Cash and cash equivalents at the end of the period were $764,644.

Full-Year 2022 Financial Highlights

  • Gross profit was $12.0 million, a 168% increase compared to a gross loss of $17.5 million in 2021.

  • Gross margin was 13% compared to a negative gross margin of 24% in 2021.

  • Adjusted EBITDA was a loss of $80.6 million compared to a loss of $160.4 million in 2021.

  • Net loss was $168.7 million, a 58% decrease compared to a loss of $397.2 million in 2021.

“2022 was a transformative year for Cronos in which we executed a business realignment, including a cost savings program, while staying laser focused on continuing to build our portfolio of borderless products,” stated Mike Gorenstein, chairman, president and CEO of Cronos. “We exceeded our originally stated goal by saving $28.7 million in operating expenses in 2022, to right-size our cost structure to be more adaptable to the changing landscape we face globally in the cannabis industry. A significant amount of work went into building the Spinach brand and creating the right products for it, which culminated in the brand achieving the number one market share in the Canadian edibles category in January 2023.”

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo by Richard T on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksSmall CapMarketsMike Gorensteinpremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!


Loading...